BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37995744)

  • 1. Central Nervous System Lymphoma.
    Shah T; Venur VA
    Semin Neurol; 2023 Dec; 43(6):825-832. PubMed ID: 37995744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central Nervous System Lymphoma: Approach to Diagnosis and Treatment.
    Correia CE; Schaff LR; Grommes C
    Cancer J; 2020; 26(3):241-252. PubMed ID: 32496457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary central nervous system lymphoma: essential points in diagnosis and management.
    Paydas S
    Med Oncol; 2017 Apr; 34(4):61. PubMed ID: 28315229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of primary central nervous system lymphoma.
    Han CH; Batchelor TT
    Cancer; 2017 Nov; 123(22):4314-4324. PubMed ID: 28950405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary central nervous system lymphoma.
    de Koning ME; Hof JJ; Jansen C; Doorduijn JK; Bromberg JEC; van der Meulen M
    J Neurol; 2024 May; 271(5):2906-2913. PubMed ID: 38112784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary central nervous system lymphoma: overview of current treatment strategies.
    Brastianos PK; Batchelor TT
    Hematol Oncol Clin North Am; 2012 Aug; 26(4):897-916. PubMed ID: 22794289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment options for central nervous system lymphomas in immunocompetent patients.
    Jahnke K; Thiel E
    Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary central nervous system lymphoma.
    Schaff LR; Grommes C
    Blood; 2022 Sep; 140(9):971-979. PubMed ID: 34699590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Primary CNS Lymphoma: Maximizing Clinical Benefit, Minimizing Neurotoxicity.
    Song KW; Batchelor T
    Curr Oncol Rep; 2021 Sep; 23(11):132. PubMed ID: 34524547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma.
    Grommes C; Rubenstein JL; DeAngelis LM; Ferreri AJM; Batchelor TT
    Neuro Oncol; 2019 Feb; 21(3):296-305. PubMed ID: 30418592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Primary Central Nervous System Lymphoma.
    Patrick LB; Mohile NA
    Curr Oncol Rep; 2015 Dec; 17(12):60. PubMed ID: 26475775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group report.
    Taylor JW; Flanagan EP; O'Neill BP; Siegal T; Omuro A; Deangelis L; Baehring J; Nishikawa R; Pinto F; Chamberlain M; Hoang-Xuan K; Gonzalez-Aguilar A; Batchelor T; Blay JY; Korfel A; Betensky RA; Lopes MB; Schiff D
    Neurology; 2013 Nov; 81(19):1690-6. PubMed ID: 24107866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma.
    Bierman P; Giglio P
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):597-609, v. PubMed ID: 16083825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Central Nervous System Lymphoma-PART 2: Modern Therapeutic Management and Future Directions.
    Lukas RV; Gondi V; Stupp R; Raizer JJ
    Oncology (Williston Park); 2018 Feb; 32(2):e11-e19. PubMed ID: 29492949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options.
    Ferreri AJ; Assanelli A; Crocchiolo R; Ciceri F
    Hematol Oncol; 2009 Jun; 27(2):61-70. PubMed ID: 19247977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma.
    Strehlow F; Bauer S; Martus P; Weller M; Roth P; Schlegel U; Seidel S; Scheibenbogen C; Korfel A; Kreher S
    J Neurooncol; 2016 Aug; 129(1):165-71. PubMed ID: 27294357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Options for Recurrent Primary CNS Lymphoma.
    Kaulen LD; Baehring JM
    Curr Treat Options Oncol; 2022 Nov; 23(11):1548-1565. PubMed ID: 36205806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment options for Primary CNS Lymphoma.
    Laghari AA; Ahmed SI; Jabbar A; Shamim MS
    J Pak Med Assoc; 2018 Mar; 68(3):499-500. PubMed ID: 29540898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary central nervous system lymphoma.
    Gerstner ER; Batchelor TT
    Arch Neurol; 2010 Mar; 67(3):291-7. PubMed ID: 20212226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.